Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion

Transfusion

Volumn 49, Issue 8, 2009, Pages 1649-1654

  Ameen, Reem ^a   Al Shemmari, Salem ^a   Al Bashir, Abdulaziz ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; RHESUS D ANTIGEN;

ADOLESCENT; ADULT; ALLOIMMUNIZATION; ANTIBODY PRODUCTION; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ARTICLE; BLOOD COMPATIBILITY; BLOOD GROUP ABO SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP RH; CHILD; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; KUWAIT; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SEX DIFFERENCE; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; ARABS; BLOOD GROUP ANTIGENS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; HUMANS; IMMUNIZATION; ISOANTIBODIES; KUWAIT; MALE; RETROSPECTIVE STUDIES;

EID: 68149145446     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02185.x     Document Type: Article

References (32)

1. Danielson C. The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease. Ther Apher Dial 2002 6 : 24 31.
2. El- Hazmi MA. Heterogeneity and version of clinical and hematological expression of hemoglobin S in Saudi Arabs. Acta Haematol 1999 88 : 67 71.
3. Perrine RP, Pembrey ME, John P, Perrine S, Shoup F. Natural history of sickle cell anemia in Saudi Arabs: a study of 270 subjects. Ann Intern Med 1978 88 : 1 6.
4. Vichinksy EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990 322 : 1617 21.
5. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000 342 : 1855 65.
6. Vichinsky EP, Luban N, Wright E, Olivieri N, Driscoll C, Pegelow CH, Adams RJ. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001a 41 : 1086 92.
7. Vichinsky EP. Current issues with blood transfusions in sickle cell disease. Semin Hematol 2001b 38 : 14 22.
8. Rosse WF, Gallagher D, Kinney TR, Castro O, Dosik H, Moohr J, Wang W, Levy PS. The cooperative study of sickle cell disease, transfusion and alloimmunization in sickle cell disease. Blood 1990 76 : 1431 7.
9. Platt OS. Preventing stroke in sickle cell anemia. N Engl J Med 2005 353 : 2743 5.
10. Adams RJ, McKie VC, Brambilla D, Carl E, Gallagher D, Nichols FT, Roach S, Abboud M, Berman B, Driscoll C, Files B, Hsu L, Hurlet A, Miller S, Olivieri N, Pegelow C, Scher C, Vichinsky E, Wang W, Woods G, Kutlar A, Wright E, Hagner S, Tighe F, Waclawiw MA. Stroke prevention trial in sickle cell anemia. Control Clin Trials 1998 19 : 110 29.
11. Ohene-Frempong K. Indications for red cell transfusion in sickle cell disease. Semin Hematol 2001 38 : 5 13. (Pubitemid 32110267)
12. Styles LA, Vichinsky E. Effect of a long-term transfusion regimen on sickle cell related illnesses. J Pediatr 1994 125 : 909 11.
13. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002 42 : 37 43.
14. Young PP, Uzieblo A, Trulock E, Lubin DM, Goodnough LT. Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia? Transfusion 2004 44 : 67 72.
15. Tahhan HR, Holbrock CT, Braddy LR, Brewer LD, Christie JD. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994 34 : 562 9.
16. Vengelen Tyler V, editor. Technical manual. 12th ed. Bethesda (MD) : American Association of Blood Banks 1996.
17. Cox JV, Steane E, Cunningham G, Frenkel EP. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988 148 : 2485 9.
18. Reisner EG, Kostyu DD, Phillips G, Walker C, Dawson DV. Alloantibody responses in multiply transfused sickle cell patients. Tissue Antigens 1987 30 : 161 6.
19. Bashawri LA. Red cell alloimmunization in sickle cell anemia patients. East Mediterr Health J 2007 13 : 1181 9.
20. Murao M, Viana MB. Risk factors for alloimmunization by patients with sickle cell disease. Braz J Med Biol Res 2005 38 : 675 82.
21. Al Saeed AH. Red blood cell alloimmunization in sickle cell disease in Eastern Province, Saudi Arabia. Med Sci Res 1997 25 : 559 60.
22. Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002 42 : 684 90.
23. Mallory D, Malamut D, Ginther A. Rare blood for patients with sickle cell anemia. Ann N Y Acad Sci 1989 565 : 432 3.
24. Diamond WJ, Brown FL, Bitterman P, Klein HG, Davey RJ, Winslow RM. Delayed hemolytic transfusion reaction presenting as sickle-cell crisis. Ann Intern Med 1980 93 : 231 4.
25. Win N, Doughty H, Telfer P, Wild BJ, Pearson TC. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 2001 41 : 323 8.
26. Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997 37 : 382 92.
27. Osby M, Shulman IA. Phenotype matching of donor red blood cell units for non alloimmunized sickle cell disease patients. Arch Pathol Lab Med 2005 129 : 190 3.
28. Frabetti F, Musiani D, Marini M, Fanelli C, Coppola S, Ghibelli L, Tazzari PL, Bontadini A, Tassi C, Conte R. White cell apoptosis in packed red cells. Transfusion 1998 38 : 1082 9.
29. Ghio M, Contini P, Mazzei C, Brenci S, Barberis G, Filaci G, Indiveri F, Puppo F. Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood 1999 93 : 1770 7.
30. Martelli AM, Tazzari R, Bortul R, Riccio M, Tabellini G, Santi S, Frabetti F, Musiani D, Bareggi R, Conte R. Nuclear matrix protein is released from apoptotic white cells during cold (1-6°C) storage of concentrated red cell units and might induce antibody response in multiply transfused patients. Transfusion 2000 40 : 169 77.
31. Mincheff M. Changes in donor leukocytes during blood storage. Implications on posttransfusion immunomodulation and transfusion associated GVHD. Vox Sang 1998 74 Suppl 2 : 189 200.
32. Pistillo MP, Tazzari PL, Gaudiano C, Cilla V, Kato T, Matsui T, Nishioka K, Capanni P, Conte R, Ferrara GB. Patients with neoplastic and non neoplastic hematological disease acquire CTLA-4 antibodies after blood transfusion. Transfusion 2001 41 : 462 9.